Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects
Author(s) -
Ghada Mikhail
Publication year - 2004
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1016/j.ehj.2004.01.013
Subject(s) - medicine , sildenafil , pulmonary hypertension , vascular resistance , pulmonary artery , adverse effect , hemodynamics , cardiology , heart transplantation , transplantation , anesthesia
The treatment of patients with pulmonary arterial hypertension remains a challenge. We set out to investigate the use of sildenafil, a selective inhibitor of phosphodiesterase type 5, in patients with this disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom